Opportunities for developing neural stem cell treatments for acute ischemic stroke: A systematic review and gap analysis
•3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell administration within 24 h.•Stem cell therapy appears to be associated with beneficial effects post stroke.•A gap analysis identified numerou...
Saved in:
Published in | Journal of clinical neuroscience Vol. 120; pp. 64 - 75 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Scotland
Elsevier Ltd
01.02.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 0967-5868 1532-2653 1532-2653 |
DOI | 10.1016/j.jocn.2023.12.021 |
Cover
Abstract | •3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell administration within 24 h.•Stem cell therapy appears to be associated with beneficial effects post stroke.•A gap analysis identified numerous opportunities for treatment development.
Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development. |
---|---|
AbstractList | Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development. •3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell administration within 24 h.•Stem cell therapy appears to be associated with beneficial effects post stroke.•A gap analysis identified numerous opportunities for treatment development. Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development. Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development.Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective treatment to mitigate damage and restore function, but efficacy results are mixed. This study aimed to systematically review the literature on stem cell therapies for early acute ischemic stroke; and identify opportunities for future research to facilitate the development of an effective stem cell-based treatment. Original research published within the last 10 years that focused on the evaluation of a stem cell-based treatment for acute ischemic stroke in adult patients or subjects was included. Risk of bias was assessed using the SYRCLE and Cochrane risk of bias tools for animal and human studies, respectively. 3,396 articles were screened, 58 full-text articles were reviewed and 33 met inclusion criteria. Many studies appeared to be at risk of bias. Study designs and results were heterogeneous. Most studies were preclinical and involved stem cell administration within 24 hours. Seven studies tested the effects of multiple administration timepoints and one investigated repeat dosing. Six studies were conducted in humans and stem cell administration ranged from 24 hours to 90 days post stroke. Most studies employed the use of mesenchymal stem cells. The most appropriate cell delivery method appeared to be intra-arterial. Evidence suggests that stem cell therapy may be associated with beneficial effects. A literature gap analysis identified numerous opportunities for treatment development. |
Author | Moore, Justin Esmaili, Nazanin Buchlak, Quinlan D |
Author_xml | – sequence: 1 givenname: Quinlan D orcidid: 0000-0001-6749-3223 surname: Buchlak fullname: Buchlak, Quinlan D email: quinlan.buchlak1@my.nd.edu.au organization: Department of Neurosurgery, Monash Health, Melbourne, VIC, Australia – sequence: 2 givenname: Nazanin surname: Esmaili fullname: Esmaili, Nazanin organization: School of Medicine, University of Notre Dame Australia, Sydney, NSW, Australia – sequence: 3 givenname: Justin surname: Moore fullname: Moore, Justin organization: Department of Neurosurgery, Monash Health, Melbourne, VIC, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38199150$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1v1DAQhi1URLeFP8AB-cglwR9xEldcqgpapEq9tGfLccbF28QOtlPYf4-XLRx6KKeRRs8zmpn3BB354AGh95TUlND207beBuNrRhivKasJo6_QhgrOKtYKfoQ2RLZdJfq2P0YnKW0JIbLh5A065j2VkgqyQb9uliXEvHqXHSRsQ8QjPMIUFufvsYc16gmnDDM2ME04R9B5Bp8PqDZrBuyS-Q6zM4WL4QHO8DlOu72jc2lGeHTwE2s_4nu9lKqnXXLpLXpt9ZTg3VM9RXdfv9xeXFXXN5ffLs6vK8NFnysj2qazQwdjLynrCW9sJyxjo6Vm0JZIazQDYbtOgG6azjDSD6RjZKAwMkb5Kfp4mLvE8GOFlNVc9i23aA9hTYpJyptG9kQW9MMTug4zjGqJbtZxp_5-qwDsAJgYUopg_yGUqH0kaqv2kah9JIoyRf4s8PkgQbmyvCKqZBx4A6OLYLIag3tZP3umm8l5Z_T0ALv_yb8B51mpwg |
Cites_doi | 10.1016/j.expneurol.2020.113275 10.1016/j.jcyt.2021.03.005 10.1161/STROKEAHA.117.018288 10.1161/CIR.0000000000001052 10.1016/j.jcyt.2018.04.004 10.1136/bmj.d5928 10.2174/187153012800493477 10.1016/j.scr.2011.07.001 10.1016/j.jcyt.2015.04.007 10.1016/j.jstrokecerebrovasdis.2022.106940 10.1016/j.acthis.2014.05.002 10.1016/j.bbr.2013.10.030 10.1016/S0140-6736(16)30513-X 10.1016/S1474-4422(17)30046-7 10.1016/j.bbr.2013.05.011 10.1016/j.bbi.2014.12.015 10.1016/j.phrs.2022.106332 10.1016/S1474-4422(17)30299-5 10.1055/s-0038-1649503 10.4103/1673-5374.177739 10.3390/ijms21207795 10.1016/j.jstrokecerebrovasdis.2018.05.001 10.1186/scrt224 10.1016/S1474-4422(22)00526-9 10.1186/s13643-021-01626-4 10.1161/STROKEAHA.119.025436 10.1016/j.expneurol.2020.113531 10.1038/jcbfm.2010.213 10.3174/ajnr.A5586 10.1186/1471-2288-14-43 10.1016/j.brainres.2013.05.024 10.3727/096368912X657251 10.1073/pnas.1103113108 10.1016/j.trsl.2016.04.003 10.1016/j.mvr.2019.01.001 10.18632/oncotarget.22155 10.1016/j.lfs.2013.12.016 10.1016/j.biopha.2018.09.084 10.1016/j.redox.2021.102197 10.1016/j.jcyt.2014.12.004 10.1016/j.ijcard.2015.03.137 10.5966/sctm.2013-0178 10.1159/000086518 10.1016/j.jstrokecerebrovasdis.2022.106453 10.3389/fnagi.2020.575990 10.1056/NEJMoa0804656 10.1016/S0092-8674(01)00409-3 10.1038/cddis.2014.359 10.1186/scrt544 10.1016/j.pneurobio.2018.05.004 10.1038/ncomms10523 10.1523/JNEUROSCI.1643-16.2016 10.1089/scd.2008.0253 10.1016/j.brainres.2017.12.017 10.3390/ijms22147703 10.26599/JNR.2018.9040002 10.1073/pnas.1121003109 10.3760/cma.j.issn.0366-6999.20122965 10.1212/WNL.0000000000011440 10.1172/jci.insight.126268 10.1016/j.jcyt.2019.04.055 10.1161/STROKEAHA.113.003379 10.5966/sctm.2014-0184 10.1016/j.jocn.2019.08.051 10.1006/exnr.2001.7853 10.1186/scrt519 10.1016/j.bbr.2015.07.048 10.1161/STROKEAHA.109.575993 |
ContentType | Journal Article |
Copyright | 2023 Elsevier Ltd Copyright © 2023 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2023 Elsevier Ltd – notice: Copyright © 2023 Elsevier Ltd. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jocn.2023.12.021 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-2653 |
EndPage | 75 |
ExternalDocumentID | 38199150 10_1016_j_jocn_2023_12_021 S0967586823004009 |
Genre | Systematic Review Journal Article |
GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABJNI ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HVGLF HZ~ IHE J1W KOM LX8 M29 M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSN SSZ T5K UHS WUQ Z5R ~G- AFCTW AGRNS RIG AAYXX CITATION EFLBG CGR CUY CVF ECM EIF NPM 7X8 ACLOT ~HD |
ID | FETCH-LOGICAL-c358t-c5647fb7ed89128034f75f22df1cbaf09fca2e5f775ea447c208b0720b1ed2213 |
IEDL.DBID | .~1 |
ISSN | 0967-5868 1532-2653 |
IngestDate | Sat Sep 27 17:15:41 EDT 2025 Sun Jul 13 01:32:46 EDT 2025 Wed Sep 10 04:22:26 EDT 2025 Sat Jul 05 17:13:11 EDT 2025 Tue Aug 26 16:31:17 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | Copyright © 2023 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c358t-c5647fb7ed89128034f75f22df1cbaf09fca2e5f775ea447c208b0720b1ed2213 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Review-4 content type line 23 |
ORCID | 0000-0001-6749-3223 |
PMID | 38199150 |
PQID | 2913449809 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2913449809 pubmed_primary_38199150 crossref_primary_10_1016_j_jocn_2023_12_021 elsevier_sciencedirect_doi_10_1016_j_jocn_2023_12_021 elsevier_clinicalkey_doi_10_1016_j_jocn_2023_12_021 |
PublicationCentury | 2000 |
PublicationDate | February 2024 2024-02-00 2024-Feb 20240201 |
PublicationDateYYYYMMDD | 2024-02-01 |
PublicationDate_xml | – month: 02 year: 2024 text: February 2024 |
PublicationDecade | 2020 |
PublicationPlace | Scotland |
PublicationPlace_xml | – name: Scotland |
PublicationTitle | Journal of clinical neuroscience |
PublicationTitleAlternate | J Clin Neurosci |
PublicationYear | 2024 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
References | Zhang, Xie, Xiong, Liu, Hu, Cao (b0140) 2018; 1680 Katan, Luft (b0015) 2018; 38 Du, Liu, Dang, Zhu, Su, Fan (b0120) 2014; 116 Dabrowska, Andrzejewska, Kozlowska, Strzemecki, Janowski, Lukomska (b0025) 2021; 336 Oh, Choi, Chang, Shin, Lee, Jeon (b0235) 2015; 17 Ramos, Vasconcelos-Dos-Santos, Lopes de Souza, Rosado-de-Castro, Barbosa da Fonseca, Gutfilen (b0275) 2013; 1522 Li, Mao, Zhang, Wan, Jing, Hua (b0220) 2016; 301 Mäkelä, Takalo, Arvola, Haapanen, Yannopoulos, Blanco (b0325) 2015; 17 Zhao, Duan, Reyes, Keene, Verfaillie, Low (b0345) 2002; 174 Ryu, Lee, Kim, Yoon (b0225) 2016; 11 Blau, Brazelton, Weimann (b0070) 2001; 105 Fischer, Harting, Jimenez, Monzon-Posadas, Xue, Savitz (b0135) 2009; 18 Kamiya, Ueda, Nito, Kamiya, Inaba, Suda (b0260) 2014; 95 Jiang, Wang, Yu, Ou, Liu, Zhao (b0270) 2013; 250 Gómez-Pinedo, Sanchez-Rojas, Benito-Martin, Lendinez, León-Espinosa, Rascón (b0085) 2018; 27 Guzman, Janowski, Walczak (b0315) 2018; 49 Nito, Sowa, Nakajima, Sakamoto, Suda, Nishiyama (b0090) 2018; 108 Hooijmans, Rovers, de Vries, Leenaars, Ritskes-Hoitinga, Langendam (b0160) 2014; 14 Boltze, Modo, Mays, Taguchi, Jolkkonen, Savitz (b0310) 2019; 50 He, Sussman, Steinberg (b0080) 2020; 12 Savitz, Dinsmore, Wu, Henderson, Stieg, Caplan (b0125) 2005; 20 [Internet]. 2020;5. Available from: http://dx.doi.org/10.1172/jci.insight.126268. Kasahara, Yamahara, Soma, Stern, Nakagomi, Matsuyama (b0215) 2016; 176 Patkar, Tate, Modo, Plevin, Carswell (b0065) 2012; 8 Chen, Tsai, Wallace, Chen, Huang, Sung (b0230) 2015; 201 Bacigaluppi, Russo, Peruzzotti-Jametti, Rossi, Sandrone, Butti (b0075) 2016; 36 Tsao, Aday, Almarzooq, Alonso, Beaton, Bittencourt (b0010) 2022; 145 Bhatia, Gupta, Khurana, Sharma, Khandelwal (b0145) 2018; 39 Banerjee, Bentley, Hamady, Marley, Davis, Shlebak (b0245) 2014; 3 Huang, Wong, Snyder, Hamblin, Lee (b0255) 2014; 5 Cui, Kerkelä, Bakreen, Nitzsche, Andrzejewska, Nowakowski (b0320) 2015; 6 Feigin, Abajobir, Abate, Abd-Allah, Abdulle, Abera (b0005) 2017; 16 Doeppner, Kaltwasser, Teli, Bretschneider, Bähr, Hermann (b0250) 2014; 5 Kalladka, Sinden, Pollock, Haig, McLean, Smith (b0300) 2016; 388 Lujan, Chanda, Ahlenius, Südhof, Wernig (b0340) 2012; 109 Ergul, Kelly-Cobbs, Abdalla, Fagan (b0050) 2012; 12 Chua, Pendharkar, Wang, Choi, Andres, Gaeta (b0330) 2011; 31 Hacke, Kaste, Bluhmki, Brozman, Dávalos, Guidetti (b0055) 2008; 359 Choi, Kim, Shon, Park, Kim, Kang (b0305) 2018; 20 Hess, Wechsler, Clark, Savitz, Ford, Chiu (b0205) 2017; 16 Kim, Efe, Zhu, Talantova, Yuan, Wang (b0335) 2011; 108 Yuan, Liao, Feng, Lou, Niu, Zhang (b0285) 2013; 4 Zhang, Zhu, Hu, Xiang, Deng, Wu (b0210) 2017; 8 Yuan, Wen, Yang, Pang, Gao, Liu (b0280) 2013; 126 Kim, Lee, Kim, Park, Kang, Lee (b0045) 2023; 32 Yang, Lavayen, Liu, Sanz, DeMars, Larochelle (b0030) 2021; 48 Moniche, Cabezas-Rodriguez, Valverde, Escudero-Martinez, Lebrato-Hernandez, Pardo-Galiana (b0165) 2023; 22 Wang, Liu, Lu, Jiang, Cui, Yu (b0240) 2015; 45 Mitkari, Nitzsche, Kerkelä, Kuptsova, Huttunen, Nystedt (b0265) 2014; 259 Eckert, Huang, Gonzalez, Kim, Hamblin, Lee (b0095) 2015; 4 Huang L, Zhang L. Neural stem cell therapies and hypoxic-ischemic brain injury. Liu, Guo, Zhou, Pan, Yan (b0195) 2019; 123 Wei, Yu, Gu, Taylor, Song, Liu (b0110) 2013; 22 Chung, Chang, Bang, Moon, Kim, Kim (b0170) 2021; 96 Yuan, Rosenberg, Liu, Grant, Ma (b0200) 2019; 21 Mao, Wang, Guo, Liu, Zheng, Chen (b0105) 2018; 6 Boese, Eckert, Hamblin, Lee (b0035) 2020; 329 Yang, Gao, Yang, Zhang, Chen, Yang (b0295) 2022; 182 Hamblin, Lee (b0020) 2021; 22 Page, McKenzie, Bossuyt, Boutron, Hoffmann, Mulrow (b0150) 2021; 10 Lam, Wang, Chin, Tong, Wang, Lo (b0185) 2020; 71 Higgins, Altman, Gøtzsche, Jüni, Moher, Oxman (b0155) 2011; 343 Wang, Sun, Sun, Gong, Liu, Wang (b0290) 2022; 31 [Internet]. 2018;Available from: http://dx.doi.org/10.1016/j.pneurobio.2018.05.004. Pendharkar, Chua, Andres, Wang, Gaeta, Wang (b0130) 2010; 41 Sharma, Sane, Gokulchandran, Khopkar, Paranjape, Sundaram (b0115) 2014; 2014 Law, Tan, Chin, Wong, Wan Yahya, Muda (b0175) 2021; 23 Korshunova I, Rhein S, García-González D, Stölting I, Pfisterer U, Barta A, Dmytriyeva O, Kirkeby A, Schwaninger M, Khodosevich K. Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells. Lee, Kim, Lee, Jung, Oh, Kim (b0190) 2020; 21 Shi, Zhang, Pu, Mao, Hu, Jiang (b0040) 2016; 7 Savitz SI, Cramer SC, Wechsler L, STEPS 3 Consortium (b0060) 2014; 45 Ergul (10.1016/j.jocn.2023.12.021_b0050) 2012; 12 Du (10.1016/j.jocn.2023.12.021_b0120) 2014; 116 Kim (10.1016/j.jocn.2023.12.021_b0335) 2011; 108 Ryu (10.1016/j.jocn.2023.12.021_b0225) 2016; 11 Choi (10.1016/j.jocn.2023.12.021_b0305) 2018; 20 Bacigaluppi (10.1016/j.jocn.2023.12.021_b0075) 2016; 36 Chung (10.1016/j.jocn.2023.12.021_b0170) 2021; 96 Lee (10.1016/j.jocn.2023.12.021_b0190) 2020; 21 Boese (10.1016/j.jocn.2023.12.021_b0035) 2020; 329 Mitkari (10.1016/j.jocn.2023.12.021_b0265) 2014; 259 Guzman (10.1016/j.jocn.2023.12.021_b0315) 2018; 49 Wei (10.1016/j.jocn.2023.12.021_b0110) 2013; 22 Wang (10.1016/j.jocn.2023.12.021_b0240) 2015; 45 Jiang (10.1016/j.jocn.2023.12.021_b0270) 2013; 250 Hess (10.1016/j.jocn.2023.12.021_b0205) 2017; 16 Shi (10.1016/j.jocn.2023.12.021_b0040) 2016; 7 Savitz SI, Cramer SC, Wechsler L, STEPS 3 Consortium (10.1016/j.jocn.2023.12.021_b0060) 2014; 45 Law (10.1016/j.jocn.2023.12.021_b0175) 2021; 23 Patkar (10.1016/j.jocn.2023.12.021_b0065) 2012; 8 Kamiya (10.1016/j.jocn.2023.12.021_b0260) 2014; 95 Feigin (10.1016/j.jocn.2023.12.021_b0005) 2017; 16 10.1016/j.jocn.2023.12.021_b0100 Hacke (10.1016/j.jocn.2023.12.021_b0055) 2008; 359 Lam (10.1016/j.jocn.2023.12.021_b0185) 2020; 71 Yang (10.1016/j.jocn.2023.12.021_b0295) 2022; 182 Savitz (10.1016/j.jocn.2023.12.021_b0125) 2005; 20 Sharma (10.1016/j.jocn.2023.12.021_b0115) 2014; 2014 Oh (10.1016/j.jocn.2023.12.021_b0235) 2015; 17 Yuan (10.1016/j.jocn.2023.12.021_b0280) 2013; 126 Tsao (10.1016/j.jocn.2023.12.021_b0010) 2022; 145 Higgins (10.1016/j.jocn.2023.12.021_b0155) 2011; 343 Mäkelä (10.1016/j.jocn.2023.12.021_b0325) 2015; 17 Nito (10.1016/j.jocn.2023.12.021_b0090) 2018; 108 Bhatia (10.1016/j.jocn.2023.12.021_b0145) 2018; 39 Doeppner (10.1016/j.jocn.2023.12.021_b0250) 2014; 5 Zhang (10.1016/j.jocn.2023.12.021_b0210) 2017; 8 Chen (10.1016/j.jocn.2023.12.021_b0230) 2015; 201 10.1016/j.jocn.2023.12.021_b0180 Boltze (10.1016/j.jocn.2023.12.021_b0310) 2019; 50 Dabrowska (10.1016/j.jocn.2023.12.021_b0025) 2021; 336 Mao (10.1016/j.jocn.2023.12.021_b0105) 2018; 6 Pendharkar (10.1016/j.jocn.2023.12.021_b0130) 2010; 41 Yuan (10.1016/j.jocn.2023.12.021_b0200) 2019; 21 Zhao (10.1016/j.jocn.2023.12.021_b0345) 2002; 174 Huang (10.1016/j.jocn.2023.12.021_b0255) 2014; 5 Eckert (10.1016/j.jocn.2023.12.021_b0095) 2015; 4 Liu (10.1016/j.jocn.2023.12.021_b0195) 2019; 123 Kim (10.1016/j.jocn.2023.12.021_b0045) 2023; 32 Li (10.1016/j.jocn.2023.12.021_b0220) 2016; 301 Yuan (10.1016/j.jocn.2023.12.021_b0285) 2013; 4 Katan (10.1016/j.jocn.2023.12.021_b0015) 2018; 38 He (10.1016/j.jocn.2023.12.021_b0080) 2020; 12 Blau (10.1016/j.jocn.2023.12.021_b0070) 2001; 105 Chua (10.1016/j.jocn.2023.12.021_b0330) 2011; 31 Zhang (10.1016/j.jocn.2023.12.021_b0140) 2018; 1680 Page (10.1016/j.jocn.2023.12.021_b0150) 2021; 10 Kalladka (10.1016/j.jocn.2023.12.021_b0300) 2016; 388 Ramos (10.1016/j.jocn.2023.12.021_b0275) 2013; 1522 Hamblin (10.1016/j.jocn.2023.12.021_b0020) 2021; 22 Fischer (10.1016/j.jocn.2023.12.021_b0135) 2009; 18 Hooijmans (10.1016/j.jocn.2023.12.021_b0160) 2014; 14 Lujan (10.1016/j.jocn.2023.12.021_b0340) 2012; 109 Cui (10.1016/j.jocn.2023.12.021_b0320) 2015; 6 Banerjee (10.1016/j.jocn.2023.12.021_b0245) 2014; 3 Gómez-Pinedo (10.1016/j.jocn.2023.12.021_b0085) 2018; 27 Yang (10.1016/j.jocn.2023.12.021_b0030) 2021; 48 Moniche (10.1016/j.jocn.2023.12.021_b0165) 2023; 22 Kasahara (10.1016/j.jocn.2023.12.021_b0215) 2016; 176 Wang (10.1016/j.jocn.2023.12.021_b0290) 2022; 31 |
References_xml | – volume: 116 start-page: 1075 year: 2014 end-page: 1084 ident: b0120 article-title: Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats publication-title: Acta Histochem – volume: 17 start-page: 1090 year: 2015 end-page: 1103 ident: b0235 article-title: Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells publication-title: Cytotherapy – volume: 8 start-page: 14 year: 2012 end-page: 25 ident: b0065 article-title: Conditionally immortalised neural stem cells promote functional recovery and brain plasticity after transient focal cerebral ischaemia in mice publication-title: Stem Cell Res – volume: 388 start-page: 787 year: 2016 end-page: 796 ident: b0300 article-title: Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study publication-title: Lancet – volume: 41 start-page: 2064 year: 2010 end-page: 2070 ident: b0130 article-title: Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia publication-title: Stroke – reference: [Internet]. 2020;5. Available from: http://dx.doi.org/10.1172/jci.insight.126268. – volume: 22 start-page: 977 year: 2013 end-page: 991 ident: b0110 article-title: Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice publication-title: Cell Transplant – volume: 6 start-page: 11 year: 2015 ident: b0320 article-title: The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity publication-title: Stem Cell Res Ther – volume: 145 start-page: e153 year: 2022 end-page: e639 ident: b0010 article-title: Heart disease and stroke statistics-2022 update: A report from the American Heart Association publication-title: Circulation – volume: 6 start-page: 74 year: 2018 end-page: 80 ident: b0105 article-title: Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: design of a multicenter randomized double-blinded placebo-controlled clinical study publication-title: J Neurorestoratology – volume: 71 start-page: 226 year: 2020 end-page: 233 ident: b0185 article-title: Topically applied adipose-derived mesenchymal stem cell treatment in experimental focal cerebral ischemia publication-title: J Clin Neurosci – volume: 8 start-page: 102067 year: 2017 end-page: 102077 ident: b0210 article-title: Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke publication-title: Oncotarget – reference: Huang L, Zhang L. Neural stem cell therapies and hypoxic-ischemic brain injury. – volume: 2014 year: 2014 ident: b0115 article-title: Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke publication-title: Stroke Res Treat – volume: 174 start-page: 11 year: 2002 end-page: 20 ident: b0345 article-title: Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats publication-title: Exp Neurol – volume: 22 start-page: 137 year: 2023 end-page: 146 ident: b0165 article-title: Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial publication-title: Lancet Neurol – volume: 20 start-page: 820 year: 2018 end-page: 829 ident: b0305 article-title: The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model publication-title: Cytotherapy – volume: 109 start-page: 2527 year: 2012 end-page: 2532 ident: b0340 article-title: Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells publication-title: Proc Natl Acad Sci U S A – volume: 96 start-page: e1012 year: 2021 end-page: e1023 ident: b0170 article-title: STARTING-2 Collaborators. Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke publication-title: Neurology – volume: 18 start-page: 683 year: 2009 end-page: 692 ident: b0135 article-title: Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect publication-title: Stem Cells Dev – volume: 23 start-page: 833 year: 2021 end-page: 840 ident: b0175 article-title: The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy publication-title: Cytotherapy – volume: 31 year: 2022 ident: b0290 article-title: Dental pulp stem cell therapy in ischemic stroke: A meta-analysis of preclinical studies publication-title: J Stroke Cerebrovasc Dis – volume: 14 start-page: 43 year: 2014 ident: b0160 article-title: SYRCLE’s risk of bias tool for animal studies publication-title: BMC Med Res Methodol – volume: 336 year: 2021 ident: b0025 article-title: Neuroinflammation evoked by brain injury in a rat model of lacunar infarct publication-title: Exp Neurol – volume: 45 start-page: 98 year: 2015 end-page: 108 ident: b0240 article-title: CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice publication-title: Brain Behav Immun – volume: 5 start-page: 129 year: 2014 ident: b0255 article-title: Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury publication-title: Stem Cell Res Ther – volume: 4 start-page: 841 year: 2015 end-page: 851 ident: b0095 article-title: Bystander effect fuels human induced pluripotent stem cell-derived neural stem cells to quickly attenuate early stage neurological deficits after stroke publication-title: Stem Cells Transl Med – volume: 7 start-page: 10523 year: 2016 ident: b0040 article-title: Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury publication-title: Nat Commun – volume: 38 start-page: 208 year: 2018 end-page: 211 ident: b0015 article-title: Global burden of stroke publication-title: Semin Neurol – volume: 48 year: 2021 ident: b0030 article-title: Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism publication-title: Redox Biol – volume: 12 start-page: 148 year: 2012 end-page: 158 ident: b0050 article-title: Cerebrovascular complications of diabetes: focus on stroke publication-title: Endocr Metab Immune Disord Drug Targets – volume: 1522 start-page: 1 year: 2013 end-page: 11 ident: b0275 article-title: Bone-marrow mononuclear cells reduce neurodegeneration in hippocampal CA1 layer after transient global ischemia in rats publication-title: Brain Res – volume: 105 start-page: 829 year: 2001 end-page: 841 ident: b0070 article-title: The evolving concept of a stem cell: entity or function? publication-title: Cell – volume: 108 start-page: 1005 year: 2018 end-page: 1014 ident: b0090 article-title: Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia publication-title: Biomed Pharmacother – volume: 16 start-page: 360 year: 2017 end-page: 368 ident: b0205 article-title: Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial publication-title: Lancet Neurol – reference: Korshunova I, Rhein S, García-González D, Stölting I, Pfisterer U, Barta A, Dmytriyeva O, Kirkeby A, Schwaninger M, Khodosevich K. Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells. – volume: 20 start-page: 101 year: 2005 end-page: 107 ident: b0125 article-title: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study publication-title: Cerebrovasc Dis – volume: 17 start-page: 392 year: 2015 end-page: 402 ident: b0325 article-title: Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model publication-title: Cytotherapy – volume: 176 start-page: 69 year: 2016 end-page: 80 ident: b0215 article-title: Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model publication-title: Transl Res – volume: 10 start-page: 89 year: 2021 ident: b0150 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: Syst Rev – volume: 4 start-page: 73 year: 2013 ident: b0285 article-title: Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion publication-title: Stem Cell Res Ther – volume: 32 year: 2023 ident: b0045 article-title: Frequency, management, and outcomes of early neurologic deterioration due to stroke progression or recurrence publication-title: J Stroke Cerebrovasc Dis – volume: 36 start-page: 10529 year: 2016 end-page: 10544 ident: b0075 article-title: Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes publication-title: J Neurosci – volume: 259 start-page: 50 year: 2014 end-page: 59 ident: b0265 article-title: Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery publication-title: Behav Brain Res – volume: 250 start-page: 222 year: 2013 end-page: 229 ident: b0270 article-title: Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia publication-title: Behav Brain Res – volume: 22 start-page: 7703 year: 2021 ident: b0020 article-title: Neural stem cells for early ischemic stroke publication-title: Int J Mol Sci – volume: 201 start-page: 668 year: 2015 end-page: 683 ident: b0230 article-title: Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats publication-title: Int J Cardiol – volume: 45 start-page: 634 year: 2014 end-page: 639 ident: b0060 article-title: Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials publication-title: Stroke – volume: 1680 start-page: 143 year: 2018 end-page: 154 ident: b0140 article-title: Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats publication-title: Brain Res – volume: 123 start-page: 74 year: 2019 end-page: 80 ident: b0195 article-title: Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke publication-title: Microvasc Res – volume: 49 start-page: 1075 year: 2018 end-page: 1082 ident: b0315 article-title: Intra-arterial delivery of cell therapies for stroke publication-title: Stroke – volume: 329 year: 2020 ident: b0035 article-title: Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains publication-title: Exp Neurol – volume: 182 year: 2022 ident: b0295 article-title: Lactobacillus plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis publication-title: Pharmacol Res – volume: 3 start-page: 1322 year: 2014 end-page: 1330 ident: b0245 article-title: Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke publication-title: Stem Cells Transl Med – volume: 359 start-page: 1317 year: 2008 end-page: 1329 ident: b0055 article-title: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke publication-title: N Engl J Med – reference: [Internet]. 2018;Available from: http://dx.doi.org/10.1016/j.pneurobio.2018.05.004. – volume: 21 start-page: 7795 year: 2020 ident: b0190 article-title: Enhancing the therapeutic potential of CCL2-overexpressing mesenchymal stem cells in acute stroke publication-title: Int J Mol Sci – volume: 5 start-page: e1386 year: 2014 ident: b0250 article-title: Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice publication-title: Cell Death Dis – volume: 343 year: 2011 ident: b0155 article-title: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials publication-title: BMJ – volume: 50 start-page: 3299 year: 2019 end-page: 3306 ident: b0310 article-title: Stem cells as an emerging paradigm in stroke 4 publication-title: Stroke – volume: 31 start-page: 1263 year: 2011 end-page: 1271 ident: b0330 article-title: Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes publication-title: J Cereb Blood Flow Metab – volume: 12 year: 2020 ident: b0080 article-title: Revisiting stem cell-based clinical trials for ischemic stroke publication-title: Front Aging Neurosci – volume: 11 start-page: 298 year: 2016 end-page: 304 ident: b0225 article-title: Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain publication-title: Neural Regen Res – volume: 27 start-page: 2453 year: 2018 end-page: 2465 ident: b0085 article-title: Evaluation of the safety and efficacy of the therapeutic potential of adipose-derived stem cells injected in the cerebral ischemic penumbra publication-title: J Stroke Cerebrovasc Dis – volume: 95 start-page: 22 year: 2014 end-page: 28 ident: b0260 article-title: Effect of repeated allogeneic bone marrow mononuclear cell transplantation on brain injury following transient focal cerebral ischemia in rats publication-title: Life Sci – volume: 301 start-page: 287 year: 2016 end-page: 292 ident: b0220 article-title: Neuroprotective effects of intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats on ischemic stroke publication-title: Behav Brain Res – volume: 39 start-page: 899 year: 2018 end-page: 904 ident: b0145 article-title: Randomized assessment of the safety and efficacy of intra-arterial infusion of autologous stem cells in subacute ischemic stroke publication-title: AJNR Am J Neuroradiol – volume: 126 start-page: 1302 year: 2013 end-page: 1309 ident: b0280 article-title: Transplantation of neural stem cells overexpressing glial cell line-derived neurotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke publication-title: Chin Med J (Engl) – volume: 16 start-page: 877 year: 2017 end-page: 897 ident: b0005 article-title: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 publication-title: Lancet Neurol – volume: 108 start-page: 7838 year: 2011 end-page: 7843 ident: b0335 article-title: Direct reprogramming of mouse fibroblasts to neural progenitors publication-title: Proc Natl Acad Sci U S A – volume: 21 start-page: 1033 year: 2019 end-page: 1048 ident: b0200 article-title: Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment publication-title: Cytotherapy – volume: 329 year: 2020 ident: 10.1016/j.jocn.2023.12.021_b0035 article-title: Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains publication-title: Exp Neurol doi: 10.1016/j.expneurol.2020.113275 – volume: 23 start-page: 833 year: 2021 ident: 10.1016/j.jocn.2023.12.021_b0175 article-title: The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy publication-title: Cytotherapy doi: 10.1016/j.jcyt.2021.03.005 – volume: 49 start-page: 1075 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0315 article-title: Intra-arterial delivery of cell therapies for stroke publication-title: Stroke doi: 10.1161/STROKEAHA.117.018288 – volume: 145 start-page: e153 year: 2022 ident: 10.1016/j.jocn.2023.12.021_b0010 article-title: Heart disease and stroke statistics-2022 update: A report from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0000000000001052 – volume: 20 start-page: 820 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0305 article-title: The combination of mannitol and temozolomide increases the effectiveness of stem cell treatment in a chronic stroke model publication-title: Cytotherapy doi: 10.1016/j.jcyt.2018.04.004 – volume: 343 year: 2011 ident: 10.1016/j.jocn.2023.12.021_b0155 article-title: The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials publication-title: BMJ doi: 10.1136/bmj.d5928 – volume: 12 start-page: 148 year: 2012 ident: 10.1016/j.jocn.2023.12.021_b0050 article-title: Cerebrovascular complications of diabetes: focus on stroke publication-title: Endocr Metab Immune Disord Drug Targets doi: 10.2174/187153012800493477 – volume: 8 start-page: 14 year: 2012 ident: 10.1016/j.jocn.2023.12.021_b0065 article-title: Conditionally immortalised neural stem cells promote functional recovery and brain plasticity after transient focal cerebral ischaemia in mice publication-title: Stem Cell Res doi: 10.1016/j.scr.2011.07.001 – volume: 17 start-page: 1090 year: 2015 ident: 10.1016/j.jocn.2023.12.021_b0235 article-title: Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells publication-title: Cytotherapy doi: 10.1016/j.jcyt.2015.04.007 – volume: 32 year: 2023 ident: 10.1016/j.jocn.2023.12.021_b0045 article-title: Frequency, management, and outcomes of early neurologic deterioration due to stroke progression or recurrence publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2022.106940 – volume: 116 start-page: 1075 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0120 article-title: Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats publication-title: Acta Histochem doi: 10.1016/j.acthis.2014.05.002 – volume: 259 start-page: 50 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0265 article-title: Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery publication-title: Behav Brain Res doi: 10.1016/j.bbr.2013.10.030 – volume: 388 start-page: 787 year: 2016 ident: 10.1016/j.jocn.2023.12.021_b0300 article-title: Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study publication-title: Lancet doi: 10.1016/S0140-6736(16)30513-X – volume: 16 start-page: 360 year: 2017 ident: 10.1016/j.jocn.2023.12.021_b0205 article-title: Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial publication-title: Lancet Neurol doi: 10.1016/S1474-4422(17)30046-7 – volume: 250 start-page: 222 year: 2013 ident: 10.1016/j.jocn.2023.12.021_b0270 article-title: Comparison of the therapeutic effects of bone marrow mononuclear cells and microglia for permanent cerebral ischemia publication-title: Behav Brain Res doi: 10.1016/j.bbr.2013.05.011 – volume: 45 start-page: 98 year: 2015 ident: 10.1016/j.jocn.2023.12.021_b0240 article-title: CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice publication-title: Brain Behav Immun doi: 10.1016/j.bbi.2014.12.015 – volume: 182 year: 2022 ident: 10.1016/j.jocn.2023.12.021_b0295 article-title: Lactobacillus plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis publication-title: Pharmacol Res doi: 10.1016/j.phrs.2022.106332 – volume: 16 start-page: 877 year: 2017 ident: 10.1016/j.jocn.2023.12.021_b0005 article-title: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(17)30299-5 – volume: 38 start-page: 208 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0015 article-title: Global burden of stroke publication-title: Semin Neurol doi: 10.1055/s-0038-1649503 – volume: 11 start-page: 298 year: 2016 ident: 10.1016/j.jocn.2023.12.021_b0225 article-title: Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain publication-title: Neural Regen Res doi: 10.4103/1673-5374.177739 – volume: 2014 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0115 article-title: Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke publication-title: Stroke Res Treat – volume: 21 start-page: 7795 year: 2020 ident: 10.1016/j.jocn.2023.12.021_b0190 article-title: Enhancing the therapeutic potential of CCL2-overexpressing mesenchymal stem cells in acute stroke publication-title: Int J Mol Sci doi: 10.3390/ijms21207795 – volume: 27 start-page: 2453 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0085 article-title: Evaluation of the safety and efficacy of the therapeutic potential of adipose-derived stem cells injected in the cerebral ischemic penumbra publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2018.05.001 – volume: 4 start-page: 73 year: 2013 ident: 10.1016/j.jocn.2023.12.021_b0285 article-title: Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion publication-title: Stem Cell Res Ther doi: 10.1186/scrt224 – volume: 22 start-page: 137 year: 2023 ident: 10.1016/j.jocn.2023.12.021_b0165 article-title: Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial publication-title: Lancet Neurol doi: 10.1016/S1474-4422(22)00526-9 – volume: 10 start-page: 89 year: 2021 ident: 10.1016/j.jocn.2023.12.021_b0150 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: Syst Rev doi: 10.1186/s13643-021-01626-4 – volume: 50 start-page: 3299 year: 2019 ident: 10.1016/j.jocn.2023.12.021_b0310 article-title: Stem cells as an emerging paradigm in stroke 4 publication-title: Stroke doi: 10.1161/STROKEAHA.119.025436 – volume: 336 year: 2021 ident: 10.1016/j.jocn.2023.12.021_b0025 article-title: Neuroinflammation evoked by brain injury in a rat model of lacunar infarct publication-title: Exp Neurol doi: 10.1016/j.expneurol.2020.113531 – volume: 31 start-page: 1263 year: 2011 ident: 10.1016/j.jocn.2023.12.021_b0330 article-title: Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.2010.213 – volume: 39 start-page: 899 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0145 article-title: Randomized assessment of the safety and efficacy of intra-arterial infusion of autologous stem cells in subacute ischemic stroke publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A5586 – volume: 14 start-page: 43 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0160 article-title: SYRCLE’s risk of bias tool for animal studies publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-43 – volume: 1522 start-page: 1 year: 2013 ident: 10.1016/j.jocn.2023.12.021_b0275 article-title: Bone-marrow mononuclear cells reduce neurodegeneration in hippocampal CA1 layer after transient global ischemia in rats publication-title: Brain Res doi: 10.1016/j.brainres.2013.05.024 – volume: 22 start-page: 977 year: 2013 ident: 10.1016/j.jocn.2023.12.021_b0110 article-title: Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice publication-title: Cell Transplant doi: 10.3727/096368912X657251 – volume: 108 start-page: 7838 year: 2011 ident: 10.1016/j.jocn.2023.12.021_b0335 article-title: Direct reprogramming of mouse fibroblasts to neural progenitors publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1103113108 – volume: 176 start-page: 69 year: 2016 ident: 10.1016/j.jocn.2023.12.021_b0215 article-title: Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model publication-title: Transl Res doi: 10.1016/j.trsl.2016.04.003 – volume: 123 start-page: 74 year: 2019 ident: 10.1016/j.jocn.2023.12.021_b0195 article-title: Mesenchymal stem cells transfer mitochondria into cerebral microvasculature and promote recovery from ischemic stroke publication-title: Microvasc Res doi: 10.1016/j.mvr.2019.01.001 – volume: 8 start-page: 102067 year: 2017 ident: 10.1016/j.jocn.2023.12.021_b0210 article-title: Transplantation of bFGF-expressing neural stem cells promotes cell migration and functional recovery in rat brain after transient ischemic stroke publication-title: Oncotarget doi: 10.18632/oncotarget.22155 – volume: 95 start-page: 22 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0260 article-title: Effect of repeated allogeneic bone marrow mononuclear cell transplantation on brain injury following transient focal cerebral ischemia in rats publication-title: Life Sci doi: 10.1016/j.lfs.2013.12.016 – volume: 108 start-page: 1005 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0090 article-title: Transplantation of human dental pulp stem cells ameliorates brain damage following acute cerebral ischemia publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2018.09.084 – volume: 48 year: 2021 ident: 10.1016/j.jocn.2023.12.021_b0030 article-title: Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism publication-title: Redox Biol doi: 10.1016/j.redox.2021.102197 – volume: 17 start-page: 392 year: 2015 ident: 10.1016/j.jocn.2023.12.021_b0325 article-title: Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model publication-title: Cytotherapy doi: 10.1016/j.jcyt.2014.12.004 – volume: 201 start-page: 668 year: 2015 ident: 10.1016/j.jocn.2023.12.021_b0230 article-title: Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2015.03.137 – volume: 3 start-page: 1322 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0245 article-title: Intra-arterial immunoselected CD34+ stem cells for acute ischemic stroke publication-title: Stem Cells Transl Med doi: 10.5966/sctm.2013-0178 – volume: 20 start-page: 101 year: 2005 ident: 10.1016/j.jocn.2023.12.021_b0125 article-title: Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study publication-title: Cerebrovasc Dis doi: 10.1159/000086518 – volume: 31 year: 2022 ident: 10.1016/j.jocn.2023.12.021_b0290 article-title: Dental pulp stem cell therapy in ischemic stroke: A meta-analysis of preclinical studies publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2022.106453 – volume: 12 year: 2020 ident: 10.1016/j.jocn.2023.12.021_b0080 article-title: Revisiting stem cell-based clinical trials for ischemic stroke publication-title: Front Aging Neurosci doi: 10.3389/fnagi.2020.575990 – volume: 359 start-page: 1317 year: 2008 ident: 10.1016/j.jocn.2023.12.021_b0055 article-title: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke publication-title: N Engl J Med doi: 10.1056/NEJMoa0804656 – volume: 105 start-page: 829 year: 2001 ident: 10.1016/j.jocn.2023.12.021_b0070 article-title: The evolving concept of a stem cell: entity or function? publication-title: Cell doi: 10.1016/S0092-8674(01)00409-3 – volume: 5 start-page: e1386 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0250 article-title: Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice publication-title: Cell Death Dis doi: 10.1038/cddis.2014.359 – volume: 6 start-page: 11 year: 2015 ident: 10.1016/j.jocn.2023.12.021_b0320 article-title: The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity publication-title: Stem Cell Res Ther doi: 10.1186/scrt544 – ident: 10.1016/j.jocn.2023.12.021_b0100 doi: 10.1016/j.pneurobio.2018.05.004 – volume: 7 start-page: 10523 year: 2016 ident: 10.1016/j.jocn.2023.12.021_b0040 article-title: Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury publication-title: Nat Commun doi: 10.1038/ncomms10523 – volume: 36 start-page: 10529 year: 2016 ident: 10.1016/j.jocn.2023.12.021_b0075 article-title: Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1643-16.2016 – volume: 18 start-page: 683 year: 2009 ident: 10.1016/j.jocn.2023.12.021_b0135 article-title: Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect publication-title: Stem Cells Dev doi: 10.1089/scd.2008.0253 – volume: 1680 start-page: 143 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0140 article-title: Comparisons of the therapeutic effects of three different routes of bone marrow mesenchymal stem cell transplantation in cerebral ischemic rats publication-title: Brain Res doi: 10.1016/j.brainres.2017.12.017 – volume: 22 start-page: 7703 year: 2021 ident: 10.1016/j.jocn.2023.12.021_b0020 article-title: Neural stem cells for early ischemic stroke publication-title: Int J Mol Sci doi: 10.3390/ijms22147703 – volume: 6 start-page: 74 year: 2018 ident: 10.1016/j.jocn.2023.12.021_b0105 article-title: Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: design of a multicenter randomized double-blinded placebo-controlled clinical study publication-title: J Neurorestoratology doi: 10.26599/JNR.2018.9040002 – volume: 109 start-page: 2527 year: 2012 ident: 10.1016/j.jocn.2023.12.021_b0340 article-title: Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1121003109 – volume: 126 start-page: 1302 year: 2013 ident: 10.1016/j.jocn.2023.12.021_b0280 article-title: Transplantation of neural stem cells overexpressing glial cell line-derived neurotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke publication-title: Chin Med J (Engl) doi: 10.3760/cma.j.issn.0366-6999.20122965 – volume: 96 start-page: e1012 year: 2021 ident: 10.1016/j.jocn.2023.12.021_b0170 article-title: STARTING-2 Collaborators. Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke publication-title: Neurology doi: 10.1212/WNL.0000000000011440 – ident: 10.1016/j.jocn.2023.12.021_b0180 doi: 10.1172/jci.insight.126268 – volume: 21 start-page: 1033 year: 2019 ident: 10.1016/j.jocn.2023.12.021_b0200 article-title: Aggregation of human mesenchymal stem cells enhances survival and efficacy in stroke treatment publication-title: Cytotherapy doi: 10.1016/j.jcyt.2019.04.055 – volume: 45 start-page: 634 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0060 article-title: Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials publication-title: Stroke doi: 10.1161/STROKEAHA.113.003379 – volume: 4 start-page: 841 year: 2015 ident: 10.1016/j.jocn.2023.12.021_b0095 article-title: Bystander effect fuels human induced pluripotent stem cell-derived neural stem cells to quickly attenuate early stage neurological deficits after stroke publication-title: Stem Cells Transl Med doi: 10.5966/sctm.2014-0184 – volume: 71 start-page: 226 year: 2020 ident: 10.1016/j.jocn.2023.12.021_b0185 article-title: Topically applied adipose-derived mesenchymal stem cell treatment in experimental focal cerebral ischemia publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2019.08.051 – volume: 174 start-page: 11 year: 2002 ident: 10.1016/j.jocn.2023.12.021_b0345 article-title: Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats publication-title: Exp Neurol doi: 10.1006/exnr.2001.7853 – volume: 5 start-page: 129 year: 2014 ident: 10.1016/j.jocn.2023.12.021_b0255 article-title: Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury publication-title: Stem Cell Res Ther doi: 10.1186/scrt519 – volume: 301 start-page: 287 year: 2016 ident: 10.1016/j.jocn.2023.12.021_b0220 article-title: Neuroprotective effects of intravenous transplantation of bone marrow mononuclear cells from 5-fluorouracil pre-treated rats on ischemic stroke publication-title: Behav Brain Res doi: 10.1016/j.bbr.2015.07.048 – volume: 41 start-page: 2064 year: 2010 ident: 10.1016/j.jocn.2023.12.021_b0130 article-title: Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia publication-title: Stroke doi: 10.1161/STROKEAHA.109.575993 |
SSID | ssj0009430 |
Score | 2.37778 |
SecondaryResourceType | review_article |
Snippet | •3,396 articles were screened and 33 met inclusion criteria.•Many studies appeared to be at risk of bias.•Most studies were preclinical and involved stem cell... Ischemic stroke is a leading cause of disability and death. Current treatments are limited. Stem cell therapy has been highlighted as a potentially effective... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 64 |
SubjectTerms | Animals Humans Ischemic Stroke - therapy Neural Stem Cells - transplantation Stem Cell Transplantation - methods |
Title | Opportunities for developing neural stem cell treatments for acute ischemic stroke: A systematic review and gap analysis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0967586823004009 https://dx.doi.org/10.1016/j.jocn.2023.12.021 https://www.ncbi.nlm.nih.gov/pubmed/38199150 https://www.proquest.com/docview/2913449809 |
Volume | 120 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1532-2653 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009430 issn: 0967-5868 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1532-2653 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009430 issn: 0967-5868 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1532-2653 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009430 issn: 0967-5868 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1532-2653 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009430 issn: 0967-5868 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1532-2653 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009430 issn: 0967-5868 databaseCode: AKRWK dateStart: 19940101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PS8MwFA6iIF7E385fRPAmdW2atI23IY6pqAcVdgtpmsgmdGNu4Mm_3feadsODCp5KSx4tea8vX5L3fSHkLIltxJw2QZanSMlxLshhnA04MzIOdSJkhuTk-4ek98Jv-6K_RK4aLgyWVda53-f0KlvXT9p1b7bHg0H7CcA3gN0Ed4owEpHEh-pfENMXn4syD5QXr_T2ICFg65o442u8hiODGqgsrpYEWfTT4PQT-KwGoe4GWa_RI-34D9wkS7bcIqv39f74Nvl4HCOenpWVTioFQEoXrCiK2pVgjdLNFBfs6bzK3DfVZja1dADzXayYh3aT0Zu9pB26kHumnupCdVnQVz2Gq9c02SEv3evnq15Qn60QmFhk08CIhKcuT22RyQhPqOIuFY6xwkUm1y6UzmhmhUtTYTXnqWFhlocpC_PIFoxF8S5ZLkel3SdUA6ZhBcxbALxwYZM8llrELBOFk64IixY5bzpVjb2Ehmpqy4YKXaDQBSpiClzQInHT76ohh0I6U5Dhf7USc6tv4fOn3WnjWgX_Ffa9Lu1o9q4YliRwmYWyRfa8z-dfj7NcCUj64J9vPSRrcMd98fcRWZ5OZvYYsM00P6mC94SsdG7ueg9fIFz5Fg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED66BLa-lK3dunS_NOjbMLFlybb2FspKsjbpw1rom5BlqSQDJ7QJ9M_vnWUn7KEb7Mlg67C5k0-fpPs-AZxmqUu4NzYqypwoOd5HJY6zkeBWpbHJpCqInDydZeMb8fNW3u7BWceFobLKNveHnN5k6_bOsPXmcDWfD38h-Eawm9FOEfVE9QL6QmJO7kF_NLkYz3bau6I5coTaR2TQcmdCmddiaUkGlafNqiBPnhufnsOfzTh0_hoOWgDJRuEb38Ceqw_h5bTdIj-Cx6sVQepN3UilMsSkbEeMYiRfidak3sxozZ5tC81DU2M3a8fmOOWlonlsd7_87b6zEdspPrPAdmGmrtidWeE1yJq8hZvzH9dn46g9XiGyqSzWkZWZyH2Zu6pQCR1SJXwuPeeVT2xpfKy8NdxJn-fSGSFyy-OijHMel4mrOE_Sd9Crl7V7D8wgrOEVTl0QvwjpsjJVRqa8kJVXvoqrAXzrnKpXQUVDd-VlC00h0BQCnXCNIRhA2vldd_xQzGgak_xfreTW6o8e9E-7r11oNf5a5HtTu-XmQXOqShCqiNUAjkPMt19PE12FYPrkP9_6BV6Nr6eX-nIyu_gA-_hEhFrwj9Bb32_cJ4Q66_Jz25WfAJWZ-8E |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opportunities+for+developing+neural+stem+cell+treatments+for+acute+ischemic+stroke%3A+A+systematic+review+and+gap+analysis&rft.jtitle=Journal+of+clinical+neuroscience&rft.au=Buchlak%2C+Quinlan+D&rft.au=Esmaili%2C+Nazanin&rft.au=Moore%2C+Justin&rft.date=2024-02-01&rft.pub=Elsevier+Ltd&rft.issn=0967-5868&rft.volume=120&rft.spage=64&rft.epage=75&rft_id=info:doi/10.1016%2Fj.jocn.2023.12.021&rft.externalDocID=S0967586823004009 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0967-5868&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0967-5868&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0967-5868&client=summon |